'Poorly designed': ICMR on BHU Covaxin safety study

The Indian Council of Medical Research Director General Dr Rajiv Bahl on Monday criticised a recently published study on the long-term safety analysis of the Covaxin in adults and adolescents for......

Should Govt Continue Covid Vax Drive?

India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......

Over 30% Covaxin takers reported adverse events: Study

Nearly one-third of 926 individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study......

Does India have enough vaccine reserves to combat another Covid wave?

Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......